Samsara BioCapital

Samsara BioCapital as of Sept. 30, 2019

Portfolio Holdings for Samsara BioCapital

Samsara BioCapital holds 18 positions in its portfolio as reported in the September 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Intercept Pharmaceuticals In 18.2 $27M 404k 66.36
Allakos (ALLK) 15.4 $23M 287k 78.63
Syros Pharmaceuticals 11.6 $17M 1.7M 9.85
Springworks Therapeutics (SWTX) 10.0 $15M 677k 21.68
Odonate Therapeutics Ord 9.3 $14M 523k 26.03
Principia Biopharma 7.4 $11M 384k 28.24
Sutro Biopharma (STRO) 7.0 $10M 1.1M 9.09
Atreca Inc Cl A (BCEL) 4.9 $7.2M 591k 12.24
Gossamer Bio (GOSS) 4.3 $6.3M 377k 16.79
Hookipa Pharma Inc equity (HOOK) 2.7 $4.0M 530k 7.50
Aravive 2.3 $3.3M 443k 7.50
Sunesis Pharmaceuticals Inc Ne 1.8 $2.6M 3.6M 0.72
Catabasis Pharmaceuticals Ord 1.1 $1.6M 300k 5.40
Urovant Sciences 1.0 $1.5M 158k 9.47
Kalvista Pharmaceuticals (KALV) 0.9 $1.4M 119k 11.60
Evelo Biosciences 0.9 $1.4M 228k 6.10
Millendo Therapeutics 0.9 $1.3M 187k 7.11
Liquidia Technologies (LQDA) 0.4 $550k 155k 3.56